Sales of Pyridam Farma Tbk and its subsidiaries (PYFA Group) Increase 127% to Rp. 630.5 Billion in 2021
Jakarta, May 6, 2022 – PT Pyridam Farma Tbk. and its subsidiary (PYFA Group) recorded a significant increase in net
- Products
Consumer Health
Biomedilab
Sanitizer & Antiseptic
Sterile/ Injection
Pyfaesthetic
Betadine Group & Guardix 
Medical Support